Serotonin type 3–receptor antagonists for chemotherapy-induced nausea and vomiting: Therapeutically equivalent or meaningfully different?

Παρόμοια τεκμήρια

• The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.
  ανά: Carmichael, J., κ.ά.
  Έκδοση: (1988)
• Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting
  ανά: Navari RM, κ.ά.
  Έκδοση: (2018-10-01)
• Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting
  ανά: Navari, Rudolph M, κ.ά.
  Έκδοση: (2018)
• Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting
  ανά: Ruhlmann, Christina, κ.ά.
  Έκδοση: (2009)
• The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting
  ανά: Palli, Swetha Rao, κ.ά.
  Έκδοση: (2015)